UA91698C2 - Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level - Google Patents
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 levelInfo
- Publication number
- UA91698C2 UA91698C2 UAA200709149A UAA200709149A UA91698C2 UA 91698 C2 UA91698 C2 UA 91698C2 UA A200709149 A UAA200709149 A UA A200709149A UA A200709149 A UAA200709149 A UA A200709149A UA 91698 C2 UA91698 C2 UA 91698C2
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- level
- conditions
- increasing
- blood glp
- Prior art date
Links
Abstract
The present invention concerns combination of an amount of a GPR119 agonist with an amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-1 level in a subject over that provided by the amount of the GPR119 agonist or the amount of the DPP-IV inhibitor alone and the use of such a combination for treating or preventing diabetes and conditions related thereto or conditions ameliorated by increasing a blood GLP-1 level.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64308605P | 2005-01-10 | 2005-01-10 | |
PCT/US2006/000510 WO2006076231A2 (en) | 2005-01-10 | 2006-01-09 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
Publications (1)
Publication Number | Publication Date |
---|---|
UA91698C2 true UA91698C2 (en) | 2010-08-25 |
Family
ID=39095985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200709149A UA91698C2 (en) | 2005-01-10 | 2006-01-09 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
Country Status (3)
Country | Link |
---|---|
CN (2) | CN101332303B (en) |
UA (1) | UA91698C2 (en) |
ZA (1) | ZA200705470B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2021235294A1 (en) * | 2020-03-11 | 2022-09-08 | Dong-A St Co., Ltd. | Pharmaceutical composition for prevention or treatment of diabetes and metabolic diseases associated therewith |
CN111840285A (en) * | 2020-06-10 | 2020-10-30 | 苏州安康盟医疗科技有限公司 | GPR17 and/or CSFR1 receptor inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1741447E (en) * | 2000-01-21 | 2013-12-11 | Novartis Ag | Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
-
2006
- 2006-01-09 UA UAA200709149A patent/UA91698C2/en unknown
- 2006-01-09 CN CN2008101004894A patent/CN101332303B/en not_active Expired - Fee Related
- 2006-01-09 CN CNA2006800064168A patent/CN101128192A/en active Pending
-
2007
- 2007-07-04 ZA ZA200705470A patent/ZA200705470B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200705470B (en) | 2008-07-30 |
CN101332303A (en) | 2008-12-31 |
CN101332303B (en) | 2012-09-26 |
CN101128192A (en) | 2008-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG158876A1 (en) | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level | |
EP1761532A4 (en) | Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
WO2010029089A3 (en) | Combination therapy for the treatment of diabetes and related conditions | |
EP1756074A4 (en) | 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
PT1928499E (en) | Use of a dpp-iv inhibitor to reduce hypoglycemic events | |
WO2006000567A3 (en) | Use of glp-1 receptor agonists and / or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i i and impaired pancreatic beta-cell function | |
MX2008013135A (en) | Use of gpr119 receptor agonists for increasing bone mass and for treating osteoporosis, and combination therapy relating thereto. | |
EP1986652A4 (en) | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
EP1978804A4 (en) | Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
EP2019677A4 (en) | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
GEP20135838B (en) | Dipeptidyl peptidase inhibitors usage at diabetes treatment | |
MX2008013304A (en) | Glp-1 compounds. | |
WO2007120936A3 (en) | Use.of vildagliptin for the treatment of diabetes | |
TW200740804A (en) | Glucokinase activators | |
TN2011000413A1 (en) | Sglt-2inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus impaired glucose tolerance or hyperglycemia | |
IL190133A0 (en) | Dipeptidyl peptidase inhibitors for treating diabetes | |
ZA200807488B (en) | Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes | |
WO2007027225A3 (en) | Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level | |
UA91698C2 (en) | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level | |
TW200738245A (en) | Pharmaceutical composition containing FBPase inhibitor | |
AU2011213703B2 (en) | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | |
ZA200802855B (en) | Dipeptidyl peptidase inhibitors for treating diabetes |